The SonoTran System is a novel proprietary ultrasound device uniquely designed by OxSonics to image, treat, and monitor target tissue regions in the oncology ward setting. The System uses diagnostic-level ultrasound pressures focused to a user-selectable target region.
It is intended that conventional ultrasound imaging, either alone or in combination with diagnostic MR or CT patient image data, can be used to guide and register treatment of target tissue regions.
The SonoTran System uses patent protected ‘see-as-you-treat’ algorithms that should allow the user to confirm that the treatment is being successfully applied to the target tissues. This feature could be extended to full 3D monitoring if utilizing CT or MR registration.
The SonoTran System has been designed in collaboration with oncology radiologists to be used efficiently in an oncology day treatment unit rather than in a radiology ward.
OxSonics plans to provide an installed base of SonoTran Systems alongside the provision of training and service and maintenance of Systems. This allows our strategic partners to focus on the commercialisation of the SonoTran Particles in combination with their therapeutic agent.